Page 51 - memoria2020online
P. 51
Memoria de actividades
2020
Suppl):Abstract nr PS5-22. Characteristics of HR+/HER2- Res 2021;81(4 Suppl):Abstract nr INVESTIGACIÓN Y PUBLICACIONES - Comunicaciones a Congresos
DOI:10.1158/1538-7445.SABCS20- PS4-38.
PS5-22 Published February 2021 patients with recurrent disease DOI:10.1158/1538-7445.SABCS20-
PS4-38 Published February 2021
https://cancerres.aacrjournals.org/ from a prospective registry of
https://cancerres.aacrjournals.org/
content/81/4_Supplement/PS5-22 unresectable locally advanced
content/81/4_Supplement/PS4-38
Poster or metastatic breast cancer:
Poster
Jara C, Rodríguez C.A, GEICAM/2014-03 (RegistEM)
Álvarez I, Falo C, Martínez Hurvitz S-A, Fasching
P, Andrés R, Cruz J, Mori 2020 SABCS, December 8-12. P.A, Park Y.H, Quiroga
M, Adrover E, Tibau A, Poster Session 7 – Wednesday, V, Badovinac Crnjevic T,
Antolín S, Margelí M, Alonso December 9, 2020: 8:00 AM CT. Fresco R, López-Valverde
J.L, Pajares B.I, Cámara Abstract PS7-08. V, Steinseifer J, Ye C and
M.C, Miralles J, Bezares S, Proceedings of the 2020 San Antonio Bardia A.
Rojo F, López-Tarruella S, Breast Cancer Virtual Symposium;
Guerrero-Zotano A. 2020 Dec 8-11; San Antonio, TX. Phase II neoadjuvant study of
Philadelphia (PA): AACR; Cancer
GEICAM/2014-03 (RegistEM): Res 2021;81(4 Suppl):Abstract nr GDC-9545 + palbociclib (palbo)
PS7-08.
a prospective registry of DOI:10.1158/1538-7445.SABCS20- vs anastrozole (A) + palbo in
PS7-08 Published February 2021
unresectable locally advanced postmenopausal women with
https://cancerres.aacrjournals.org/
or metastatic breast cancer: estrogen receptor-positive,
content/81/4_Supplement/PS7-08
characteristics of a subset of HER2-negative, untreated early
Poster
patients with Triple Negative breast cancer (ER+/HER2- eBC)
De la Cruz Merino L,
subtype Gion M, Cruz J, Alonso 2020 SABCS, December 8-12.
J.L, Quiroga V, Moreno F, Ongoing Clinical Trials Session 1.
2020 SABCS, December 8-12. Santisteban M, Andrés R, December 9, 2020. Number OT-09-
Poster Session 7 – Wednesday, Holgado E, Palazón Carrión 06.
December 9, 2020: 8:00 AM CT. N, Rodríguez Rodríguez Proceedings of the 2020 San
Abstract PS7-25. L, Soto A, Cortés J, Cortés Antonio Breast Cancer Virtual
Proceedings of the 2020 San Salgado A, Ramos M, Casas Symposium; 2020 Dec 8-11; San
Antonio Breast Cancer Virtual M, Chiesa M, Bezares S, Antonio, TX. Philadelphia (PA):
Symposium; 2020 Dec 8-11; San Caballero R, Rojo F. AACR. Cancer Res February 15
Antonio, TX. Philadelphia (PA): 2021 (81) (4 Supplement) OT-09-06;
AACR; Cancer Res 2021;81(4 Association of Tumor DOI: 10.1158/1538-7445.SABCS20-
Suppl):Abstract nr PS7-25. OT-09-06
DOI: Infiltrating Lymphocytes (TILs)
10.1158/1538-7445.SABCS20- https://cancerres.aacrjournals.org/
PS7-25 Published February 2021 density and PD-L1 expression
content/81/4_Supplement/OT-09-06
https://cancerres.aacrjournals.org/ with pembrolizumab (P) plus
Poster
content/81/4_Supplement/PS7-25 gemcitabine (Gem) efficacy in
Ettl J, Laird AD, Blum
Poster patients with HER2-negative JL, Rugo HS, Hurvitz SA,
Martín M, Roché H, Im Y-H,
Álvarez I, Guerrero-Zotano A, advanced breast cancer (ABC) Goodwin A, Yerushalmi
López-Tarruella S, Martínez R, Usari T, Lanzalone
P, Mori M, Falo C, Antolín from the GEICAM/2015-04 S, Czibere A, Hopkins J,
S, Rodríguez C.A, Margelí Albacker LA, Mina LA,
M, Garau I, Tibau A, Moreno (PANGEA-Breast) study Litton JK.
D, Cruz J, Echarri M.J, Lao
J, Rodríguez-Lescure A, 2020 SABCS, December 8-12. A retrospective analysis of
Miralles J, Bezares S, Rojo F, Poster Session 4 – Wednesday,
Jara C. December 9, 2020: 8:00 AM CT. association of MYC and RAD21
Abstract PS4-38.
Proceedings of the 2020 San Antonio amplification with final overall
Breast Cancer Virtual Symposium;
2020 Dec 8-11; San Antonio, TX. survival (OS) data in the
Philadelphia (PA): AACR; Cancer
51
